Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial

Clinical trial NCT04865107 · COMPLETED

Trial details

NCT number: NCT04865107
Sponsor: Ottawa Hospital Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Acute Respiratory Distress Syndrome

Start date: 2021-04-27
Primary completion: 2022-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.